The effect of lithium on expression of genes for inositol biosynthetic enzymes in mouse hippocampus; a comparison with the yeast model

Molecular Brain Research

Volumn 115, Issue 2, 2003, Pages 104-110

  Shamir, Alon ^a   Shaltiel, Galit ^a   Greenberg, Miriam L ^b   Belmaker, R H ^a,c   Agam, Galila ^a,c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b WAYNE STATE UNIVERSITY   (United States)

^c MENTAL HEALTH CENTER   (Israel)

Author keywords

Frontal cortex; Hippocampus; Inositol monophosphatase; Lithium; Mouse; mRNA levels; Myo inositol 1 phosphate synthase; Yeast

Indexed keywords

GLUCOSE 6 PHOSPHATE; INOSITOL; LITHIUM; MESSENGER RNA; MYOINOSITOL 1 PHOSPHATE SYNTHASE; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; FRONTAL CORTEX; GENE ACTIVATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC CODE; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; YEAST;

MAMMALIA;

EID: 0038107503     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00120-7     Document Type: Article

References (54)

1. Agam G., Shamir A., Shaltiel G., Greenberg M.L. Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs. Bipolar Disord. 4:2002;15-20.
2. Allison J.H., Blisner M.E., Holland W.H., Hipps P.P., Sherman W.R. Increased brain myo-inositol 1-phosphate in lithium-treated rats. Biochem. Biophys. Res. Commun. 71:1976;664-670.
3. Berridge M.J. Phosphoinositides and signal transductions. Rev. Clin. Basic Pharm. 5:(Suppl.):1985;5S-13S.
4. Bitran J.A., Manji H.K., Potter W.Z., Gusovsky F. Down-regulation of PKC alpha by lithium in vitro. Psychopharmacol. Bull. 31:1995;449-452.
5. Chen G., Rajkowska G., Du F., Seraji-Bozorgzad N., Manji H.K. Enhancement of hippocampal neurogenesis by lithium. J. Neurochem. 75:2000;1729-1734.
6. Chen G., Yuan P.X., Jiang Y.M., Huang L.D., Manji H.K. Lithium increases tyrosine hydroxylase levels both in vivo and in vitro. J. Neurochem. 70:1998;1768-1771.
7. Chen G., Zeng W.Z., Yuan P.X., Huang L.D., Jiang Y.M., Zhao Z.H., Manji H.K. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J. Neurochem. 72:1999;879-882.
8. Chuang D.M., Chen R.W., Chalecka-Franaszek E., Ren M., Hashimoto R., Senatorov V., Kanai H., Hough C., Hiroi T., Leeds P. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord. 4:2002;129-136.
9. Cimarosti H., Rodnight R., Tavares A., Paiva R., Valentim L., Rocha E., Salbego C. An investigation of the neuroprotective effect of lithium in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation. Neurosci. Lett. 315:2001;33-36.
10. Council N.R. Guide for the Care and Use of Laboratory Animals. 1996;National Academy Press, Washington, DC.
11. Eisenberg F. Jr. D-myoinositol 1-phosphate as product of cyclization of glucose 6-phosphate and substrate for a specific phosphatase in rat testis. J. Biol. Chem. 242:1967;1375-1382.
12. Freimer N.B., Reus V.I., Escamilla M., Spesny M., Smith L., Service S., Gallegos A., Meza L., Batki S., Vinogradov S., Leon P., Sandkuijl L.A. An approach to investigating linkage for bipolar disorder using large Costa Rican pedigrees. Am. J. Med. Genet. 67:1996;254-263.
13. Greenberg M.L., Lopes J.M. Genetic regulation of phospholipid biosynthesis in Saccharomyces cerevisiae. Microbiol. Rev. 60:1996;1-20.
14. Greenberg M.L., Reiner B., Henry S.A. Regulatory mutations of inositol biosynthesis in yeast: isolation of inositol-excreting mutants. Genetics. 100:1982;19-33.
15. Grimes C.A., Jope R.S. CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J. Neurochem. 78:2001;1219-1232.
16. Hallcher L.M., Sherman W.R. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 255:1980;10896-10901.
17. Hashimoto R., Hough C., Nakazawa T., Yamamoto T., Chuang D.M. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J. Neurochem. 80:2002;589-597.
18. Hirsch J.P., Henry S.A. Expression of the Saccharomyces cerevisiae inositol-1-phosphate synthase (INO1) gene is regulated by factors that affect phospholipid synthesis. Mol. Cell. Biol. 6:1986;3320-3328.
19. Honchar M.P., Ackermann K.E., Sherman W.R. Chronically administered lithium alters neither myo-inositol monophosphatase activity nor phosphoinositide levels in rat brain. J. Neurochem. 53:1989;590-594.
20. Horikoshi T., Danenberg K.D., Stadlbauer T.H., Volkenandt M., Shea L.C., Aigner K., Gustavsson B., Leichman L., Frosing R., Ray M., et al. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res. 52:1992;108-116.
21. Jiranek V., Graves J.A., Henry S.A. Pleiotropic effects of the opi1 regulatory mutation of yeast: its effects on growth and on phospholipid and inositol metabolism. Microbiology. 144:1998;2739-2748.
22. Johnson M.D. The arabidopsis thaliana myo-inositol 1-phosphate synthase (EC 5.5.1.4). Plant Physiol. 105:1994;1023-1024.
23. Jope R.S. A bimodal model of the mechanism of action of lithium. Mol. Psychiatry. 4:1999;21-25.
24. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA. 93:1996;8455-8459.
25. Lee Y., Hamamura T., Ohashi K., Fujiwara Y., Kuroda S. The effect of lithium on methamphetamine-induced regional Fos protein expression in the rat brain. Neuroreport. 10:1999;895-900.
26. Loewy B.S., Henry S.A. The INO2 and INO4 loci of Saccharomyces cerevisiae are pleiotropic regulatory genes. Mol. Cell Biol. 4:1984;2479-2485.
27. Lopez F., Leube M., Gil-Mascarell R., Navarro-Avino J.P., Serrano R. The yeast inositol monophosphatase is a lithium- and sodium-sensitive enzyme encoded by a non-essential gene pair. Mol. Microbiol. 31:1999;1255-1264.
28. Majumder A.L., Johnson M.D., Henry S.A. 1L-myo-inositol-1-phosphate synthase. Biochim. Biophys. Acta. 1348:1997;245-256.
29. Manji H.K., Bersudsky Y., Chen G., Belmaker R.H., Potter W.Z. Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol. Neuropsychopharmacology. 15:1996;370-381.
30. Moore C.M., Breeze J.L., Gruber S.A., Babb S.M., Frederick B.B., Villafuerte R.A., Stoll A.L., Hennen J., Yurgelun-Todd D.A., Cohen B.M., Renshaw P.F. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord. 2:2000;207-216.
31. Murray M., Greenberg M.L. Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate. Mol. Microbiol. 36:2000;651-661.
32. Nemanov L., Ebstein R., Belmaker R., Osher Y., Agam G. Effect of bipolar disorder on lymphocyte inositol monophosphatase mRNA levels. Int. J. Neuropsycopharmacol. 2:1999;25-29.
33. Ozaki N., Chuang D.M. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J. Neurochem. 69:1997;2336-2344.
34. Parthasarathy L.K., Seelan R.S., Wilson M.A., Vadnal R.E., Parthasarathy R.N. Regional changes in rat brain inositol monophosphatase 1 (IMPase1) activity with chronic lithium treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry. 5769:2002;1-6.
35. Patishi Y., Lubrich B., Berger M., Kofman O., van Calker D., Belmaker R.H. Differential uptake of myo-inositol in vivo into rat brain areas. Eur. Neuropsychopharmacol. 6:1996;73-75.
36. Renshaw P.F., Joseph N.E., Leigh J.S. Jr. Chronic dietary lithium induces increased levels of myo-inositol-1-phosphatase activity in rat cerebral cortex homogenates. Brain Res. 380:1986;401-404.
37. Schuller H.J., Richter K., Hoffmann B., Ebbert R., Schweizer E. DNA binding site of the yeast heteromeric Ino2p/Ino4p basic helix-loop-helix transcription factor: structural requirements as defined by saturation mutagenesis. FEBS Lett. 370:1995;149-152.
38. Schwank S., Ebbert R., Rautenstrauss K., Schweizer E., Schuller H.J. Yeast transcriptional activator INO2 interacts as an Ino2p/Ino4p basic helix-loop-helix heteromeric complex with the inositol/choline-responsive element necessary for expression of phospholipid biosynthetic genes in Saccharomyces cerevisiae. Nucl. Acids Res. 23:1995;230-237.
39. Shamir A., Ebstein R.P., Nemanov L., Zohar A., Belmaker R.H., Agam G. Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy. Mol. Psychiatry. 3:1998;481-482.
40. Sjoholt G., et al. Characterization and polymorphism screening of inositol monophosphatase genes in manic-depressive patients. Lithium 50th Anniversary of Lithium in Clinical Medicine, Lexington, KY. 1999.
41. Sjoholt G., Gulbrandsen A.K., Lovlie R., Berle J., Molven A., Steen V.M. A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients. Mol. Psychiatry. 5:2000;172-180.
42. Sjoholt G., Molven A., Lovlie R., Wilcox A., Sikela J.M., Steen V.M. Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA). Genomics. 45:1997;113-122.
43. Soares J.C., Chen G., Dippold C.S., Wells K.F., Frank E., Kupfer D.J., Manji H.K., Mallinger A.G. Concurrent measures of protein kinase C and phosphoinositides in lithium-treated bipolar patients and healthy individuals: a preliminary study. Psychiatry Res. 95:2000;109-118.
44. Stein A.J., Geiger J.H. The crystal structure and mechanism of 1-L-myo-inositol-1-phosphate synthase. J. Biol. Chem. 277:2002;9484-9491.
45. Tanapat P., Galea L.A., Gould E. Stress inhibits the proliferation of granule cell precursors in the developing dentate gyrus. Int. J. Dev. Neurosci. 16:1998;235-239.
46. Vaden D.L., Ding D., Peterson B., Greenberg M.L. Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis. J. Biol. Chem. 276:2001;15466-15471.
47. Wagner C., Blank M., Strohmann B., Schuller H.J. Overproduction of the Opi1 repressor inhibits transcriptional activation of structural genes required for phospholipid biosynthesis in the yeast Saccharomyces cerevisiae. Yeast. 15:1999;843-854.
48. Wang H.Y., Johnson G.P., Friedman E. Lithium treatment inhibits protein kinase C translocation in rat brain cortex. Psychopharmacol. (Berl.). 158:2001;80-86.
49. Wang L., Liu X., Lenox R.H. Transcriptional regulation of mouse MARCKS promoter in immortalized hippocampal cells. Biochem. Biophys. Res. Commun. 292:2002;969-979.
50. Wong Y.H., Kalmbach S.J., Hartman B.K., Sherman W.R. Immunohistochemical staining and enzyme activity measurements show myo-inositol-1-phosphate synthase to be localized in the vasculature of brain. J. Neurochem. 48:1987;1434-1442.
51. Wong Y.H., Mauck L.A., Sherman W.R. L-myo-Inositol-1-phosphate synthase from bovine testis. Methods Enzymol. 90:(Pt. E):1982;309-314.
52. Yoshikawa T., Padigaru M., Karkera J.D., Sharma M., Berrettini W.H., Esterling L.E., Detera-Wadleigh S.D. Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2). Mol. Psychiatry. 5:2000;165-171.
53. Yoshikawa T., Turner G., Esterling L.E., Sanders A.R., Detera-Wadleigh S.D. A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder. Mol. Psychiatry. 2:1997;393-397.
54. Yuan P.X., Chen G., Huang L.D., Manji H.K. Lithium stimulates gene expression through the AP-1 transcription factor pathway. Mol. Brain Res. 58:1998;225-230.